What's up with Biotech in MA so far in 2023?
- Karen Whitney
- Sep 7, 2023
- 1 min read
Mass Bio released their Industry snapshot today, Sept 7 2023. It's focus is more about the pharma industry vs tools & medical devices but does have some interesting sections. There has been significant growth over the last 20 yrs in Biotech in MA from 36,689 employees in 2002 to 113,994 employees in 2022.
There are sections on VC & NIH funding, real estate, job growth, biomanufacturing, locations of VC funded companies, IPOS and exits. Also included is data around regional workforce and R&D/drug pipelines.
Highlights include:
The biopharma R&D workforce experienced year-over-year employment growth of 8.5%, while biomanufacturing grew by 6.3%, for a total growth rate of 6.9%.
In the first half of 2023, Massachusetts-based companies received $3.73 billion in VC funding.
Massachusetts headquartered companies received 32% of all VC dollars invested in the industry.
Construction was completed on 6 million square feet of life sciences-specific space across Massachusetts in 2022.
Massachusetts’ drug development pipeline is 14.9% of the U.S. pipeline.
The link to the report is below.
The article gave a helpful look at how biotech in Massachusetts keeps shifting with funding, hiring, and research focus. It felt realistic, not overly hopeful or negative. While reading it, I thought about my own busy semester when I was balancing science courses and outside work and had to Complete my online calculas class just to stay afloat. It reminded me that fast moving fields demand flexibility and support.
The article gives a clear look at how biotech in Massachusetts keeps growing through research jobs, funding, and steady innovation, even when markets feel unsure. During one rough semester, I actually had to pay to do my class because my workload felt just as overwhelming as the pace described here. Reading this made me think about how growth, whether in school or industry, often comes with pressure that needs real support to manage.